From: Salpingectomy before assisted reproductive technologies: a systematic literature review
OVARIAN RESERVE | |||||||
---|---|---|---|---|---|---|---|
Authors & Years | Patients | AMH ± SD | p | AFC ± SD/range | p | FSH ± SD/range | p |
Surrey et al. [8] | a) 32 SLP (HY) Type: not specified b) 15 PTO (HY) c) 35 no surgery (TF no HY) d) 12 tubal ligation | n.r. |  | n.r. |  | a) 7.07 ± 0.12 b) 6.65 ± 0.42 c) 7.08 ± 0.23 d) 7.47 ± 0.25 | ns |
Chan et al. [13] | 32 SLP (ECP) a) 18 unilateral LPS b) 14 unilateral LPT | n.r | - | Operated site a) 5. 0 (3.0-7.3) b) 6.5 (1.8-10.3) Non operated site a) 7.5 (4.8-8.3) b) 4.0 (2.8-9.3) | a) .05 b) ns | n.r | - |
Gelbaya et al. [10] | a) 40 SLP (HY) Type: 16 unilateral, 24 bilateral b) 25 PTD Type: 9 unilateral, 16 bilateral c) 103 no surgery (tubal factor, no HY) | n.r | - | n.r | - | IU/L a) 6.8 ± 1.3 pre 7.61 ± 2.31 post b) 6.4 ± 1.5 pre 6.35 ± 1.51 post c) 6.6 ± 2.3 pre 6.71 ± 2.32 post | a) .05 b) ns c) ns |
Sezik et al. [16] | a) 12 total hysterectomy + bilateral SLP b) 12 total hysterectomy without SLP | n.r | - | n.r | - | a) Basal 4.8 ± 1.4 1 month 4.2 ± 1.6 6 months 4.4 ± 2.1 b) Basal 5.9 ± 1.6 1 month 5.2 ± 1.6 6 months 5.5 ± 1.2 | ns |
Nakagawa et al. [17] | a) 6 SLP (HY) Type: not specified b) 11 PTD (HY) | n.r | - | n.r | - | IU/L Before surgery a) 8.0 ± 2.9 b) 6.8 ± 1.1 After surgery a) 8.6 ± 4.0 b) 14.1 ± 9.3 | a) ns b) ns |
Orvieto et al. [18] | a) 15 uni/bilateral SLP (HY) | n.r | - | Before surgery a) 5.6 ± 2.5 affected side 11.4 ± 4.5 both side After surgery a) 4.7 ± 2.3 affected side 9.5 ± 4.9 both side | a) .05 | n.r | - |
Xi et al. [20] | a) 76 SLP (ECP) - 44 unilateral - 32 bilateral b) 80 no surgery (healthy subjects) | n.r | - | n.r | - | IU/L Before surgery a) 6.9 ± 1.5 7.5 ± 1.5 7.0 ± 1.5 After surgery a) 7.2 ± 1.6 7.3 ± 1.2 7.2 ± 1.4 b) 7.2 ± 1.8 | a) ns |
Na et al. [21] | a) 41 SLP (HY) Type: not specified b) 56 sclerotherapy (HY) | n.r | - | n.r | - | IU/L a) 8.2 ± 4.6 b) 10.9 ± 17.1 | ns |
Grynnerup et al. [25] | a) 16 SLP (HY) Type: not specified b) 42 no surgery (TF, with or without HY) c) 13 no surgery (unexplained infertility, no HY) | pmol/L a) 16,1 (5,2-54) b) 23,4 (3,5-50) c) 21.8 (12–64) | a) ns b) ns c) ns | n.r | - | n.r | - |
Uyar et al. [23] | a) 33 patients (ECP) - 26 unilateral SLP - 3 salpingostomy b) 49 MTX (ECP) c) 80 no surgery | n.r | - | a) 10.1 ± 3.5 b) 10.3 ± 4.1 c) 10.1 ± 3.5 | a) ns b) ns c) ns | IU/L a) 7.7 ± 3.8 b) 7.7 ± 2.3 c) 7.9 ± 1.9 | a) ns b) ns c) ns |
Ni et al. [22] | 60 SLP (ECP, HY) a) 26 bilateral b) 34 unilateral c) 23 PTO (HY) d) 51 no surgery (TF, no HY) | pg/mL a) 90.00 b) 100.00 c) 100.00 d) 110.00 | a) ns b) ns c) ns d) ns | a) 9 b) 10 c) 11 d) 11 | a) ns b) ns c) ns d) ns | IU/L a) 7.35 ± 1.59 b) 7.17 ± 1.16 c) 7.64 ± 2.10 d) 7.13 ± 1.57 | a) ns b) ns c) ns d) ns |
Findley et al. [26] | a) 15 hysterectomy + bilateral SLP b) 15 hysterectomy with no SLP | a) Basal 2.26 ± 2.72 4–6 weeks 1.03 ± 1.04 3 months 1.86 ± 1.99 b) Basal 2.25 ± 2.57 4–6 weeks 1.25 ± 2.09 3 months 1.82 ± 3.12 | ns | n.r | - | n.r | - |
Hill et al. [27] | a) 36 SLP (ECP) Type: unilateral b) 153 MTX (ECP) | n.r | - | a) 10 (3–50) pre 10 (4–45) post b) 12 (1–53) pre 13 (1–60) post | a) ns b) ns | IU/L a) 7.2 (2.6 -16.0) pre 7.9 (5.1-10.4) post b) 6.9 (2.4-14.2) pre 7.2 (2.3-16.3) post | a) ns b) ns |
Pereira et al. [29] | a) 37 SLP (ECP) Type: unilateral b) 107 MTX (ECP) | n.r | - | n.r | - | mIU/mL a) 4.98 ± 2.19 pre 4.87 ± 2.97 post b) 4.81 ± 2.75 pre 4.94 ± 2.05 post | a) ns b) ns |
Ye et al. [28] | 124 SLP (HY, ECP, TOA) a) 83 unilateral b) 41 bilateral c) 74 no surgery (infertility, no TF) | fmol/mL a) 167,56 ± 127,03 b) 127,11 ± 93,23 c) 183.48 ± 104,37 | .05 | a) 10,7 ± 3,62 b) 9,58 ± 3,73 c) 11,2 ± 4,16 | ns | mIU/mL a) 8.42 ± 2.3 b) 9.13 ± 3.2 c) 7.85 ± 2.69 | .05 |
Venturella et al. [31] | a) 91 SLP standard b) 95 SLP wide Type: bilateral | ng/mL Before surgery a) 0.93 ± 1.13 b) 0.86 ± 1.01 Δ After surgery a) -0.09 ± 0.24 (Δ) b) -0.07 ± 0.22 (Δ) | a) ns b) ns | Before surgery a) 7.8 ± 4.23 b) 6.82 ± 4.68 Δ After surgery a) -0.33 ± 0.73 (Δ) b) -0.26 ± 0.61 (Δ) | a) ns b) ns | mIU/mL Before surgery a) 12.9 ± 9.71 b) 12.39 ± 7.88 After surgery a) 0.47 ± 0.86 b) 0.37 ± 0.84 | a) ns b) ns |